ATNM - Actinium Pharmaceuticals, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 8.71

Open

$ 8.59

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 8.36 - $ 8.74

52 Week Range

$ 4.00 - $ 9.86

Volume

157,603

Average Volume

Market Cap

259.41M

Beta (5Y Monthly)

$ 0.78

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-26-2024	03-31-2024	10-Q
2	03-29-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-13-2022	03-31-2022	10-Q
10	03-25-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	07-30-2021	06-30-2021	10-Q
13	05-14-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	10-23-2020	09-30-2020	10-Q
16	08-14-2020	06-30-2020	10-Q
17	06-30-2020	03-31-2020	10-Q
18	05-08-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	03-15-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-16-2018	12-31-2017	10-K
27	11-03-2017	09-30-2017	10-Q
28	08-04-2017	06-30-2017	10-Q
29	05-15-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	10-28-2016	09-30-2016	10-Q
32	07-29-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-11-2016	12-31-2015	10-K
35	10-30-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-08-2015	03-31-2015	10-Q
38	03-16-2015	12-31-2014	10-K
39	10-31-2014	09-30-2014	10-Q
40	08-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Actinium Announces KOL Webinar To Highligh...
05/07/2024 12:21:50

Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern and Principal Inve...

HC Wainwright & Co. Reiterates Buy on Acti...
05/02/2024 17:13:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price t...

Cantor Fitzgerald Reiterates Overweight on...
04/30/2024 14:14:58

Cantor Fitzgerald analyst Kristen Kluska reiterates Actinium Pharma (AMEX:ATNM) with a Overweight and maintains $21 price ta...

HC Wainwright & Co. Reiterates Buy on Acti...
04/29/2024 10:10:05

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price t...

$actinium-highlights-ability-of-iomab-b-to-overcome-high-risk-tp53-mutation-resulting-in-improvement-in-overall-survival-in-patients-with-active-relapsed-refractory-aml-at-the-european-bone-marrow-transplant-annual-meeting$

Actinium Highlights Ability Of Iomab-B To ...
04/18/2024 12:11:26

-- Iomab-B led bone marrow transplant produced high rates of complete remission and durable complete remission regardless of TP...

HC Wainwright & Co. Reiterates Buy on Acti...
04/01/2024 14:16:58

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price t...

Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 12:24:46

Cantor Fitzgerald analyst Kristen Kluska reiterates Actinium Pharma (AMEX:ATNM) with a Overweight and maintains $21 price ta...

$actinium-announces-iomab-b-phase-3-sierra-trial-results-demonstrating-survival-benefit-in-high-risk-relapsed-or-refractory-acute-myeloid-leukemia-patients-with-tp53-mutations-accepted-for-oral-presentation-at-the-european-bone-marrow-transplant-annual-meeting$

Actinium Announces Iomab-B Phase 3 SIERRA ...
04/01/2024 12:09:44

- The SIERRA results demonstrate Iomab-B's ability to overcome the negative impact of a TP53 mutation in patients who othe...

HC Wainwright & Co. Reiterates Buy on Acti...
03/26/2024 16:14:50

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price t...

Actinium Announces Clinical Trial to Study...
03/26/2024 11:21:51

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjuga...

Maxim Group Maintains Buy on Actinium Phar...
03/19/2024 16:59:29

Maxim Group analyst Jason McCarthy maintains Actinium Pharma (AMEX:ATNM) with a Buy and raises the price target from $20 to ...

Watching Actinium Pharmaceuticals; HC Wain...
03/19/2024 15:24:58

HC Wainwright & Co. Maintains Buy on Actin...
03/19/2024 15:19:10

HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price ta...

Actinium Pharmaceuticals Disclosed The Lau...
03/14/2024 10:11:56

HC Wainwright & Co. Maintains Buy on Actin...
03/11/2024 14:37:57

HC Wainwright & Co. analyst Joseph Pantginis maintains Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price ta...

Actinium Pharmaceuticals Has Launched A St...
03/11/2024 11:46:37

$actinium-announces-iomab-b-markedly-increases-long-term-survival-in-older-patients-with-active-relapsedrefractory-acute-myeloid-leukemia-in-phase-3-sierra-trial-at-2024-tandem-meetings--transplantation--cellular-therapy-meetings-of-astct-and-cibmtr$

Actinium Announces Iomab-B Markedly Increa...
02/26/2024 12:38:42

$actinium-highlights-improved-survival-with-iomab-b-in-tp53-positive-relapsed-refractory-acute-myeloid-leukemia-patients-in-sierra-trial-and-other-presentations-at-2024-transplantation--cellular-therapy-meetings-of-astct-and-cibmtr$

Actinium Highlights Improved Survival With...
02/23/2024 12:43:56

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
02/09/2024 21:31:09

Actinium Pharmaceuticals Granted U.S. Pate...
12/19/2023 12:35:05

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11844799